AAAAAA
Results:
1-13
|
Results: 13
Authors:
Bengala, C
Pazzagli, I
Innocenti, F
Donati, S
Favre, C
Menconi, MC
Greco, F
Danesi, R
Orlandini, C
Guarneri, V
Del Tacca, M
Conte, PF
Citation: C. Bengala et al., High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC), ANN ONCOL, 12(1), 2001, pp. 69-74
Authors:
Conte, P
Gennari, A
Guarneri, V
Landucci, E
Donati, S
Salvadori, B
Bengala, C
Orlandini, C
Baldini, E
Citation: P. Conte et al., Epirubicin/taxane combinations in breast cancer: Experience from several Italian trials, ONCOLOGY-NY, 15(5), 2001, pp. 21-23
Authors:
Conte, P
Gennari, A
Landucci, E
Guarneri, V
Donati, S
Salvadori, B
Bengala, C
Orlandini, C
Citation: P. Conte et al., New combinations with epirubicin in advanced breast cancer, ONCOLOGY-NY, 15(5), 2001, pp. 24-27
Authors:
Conte, PF
Gennari, A
Donati, S
Salvadori, B
Baldini, E
Bengala, C
Pazzagli, I
Orlandini, C
Danesi, R
Fogli, S
Del Tacca, M
Citation: Pf. Conte et al., Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study, BREAST CANC, 68(2), 2001, pp. 171-179
Authors:
Ricci, S
Antonuzzo, A
Galli, L
Ferdeghini, M
Bodei, L
Orlandini, C
Conte, PF
Citation: S. Ricci et al., Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide, ANN ONCOL, 11(9), 2000, pp. 1127-1130
Authors:
Ricci, S
Antonuzzo, A
Galli, L
Orlandini, C
Ferdeghini, M
Boni, G
Roncella, M
Mosca, F
Conte, PF
Citation: S. Ricci et al., Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors, AM J CL ONC, 23(4), 2000, pp. 412-415
Authors:
Ricci, S
Antonuzzo, A
Galli, L
Tibaldi, C
Bertuccelli, M
Pegna, AL
Petruzzelli, S
Algeri, R
Bonifazi, V
Fioretto, ML
Orlandini, C
Conte, PF
Citation: S. Ricci et al., Gemcitabine monotherapy in elderly patients with advanced iron-small cell lung cancer - A multicenter phase II study, LUNG CANC, 27(2), 2000, pp. 75-80
Authors:
Gennari, A
Donati, S
Danesi, R
Fogli, S
Orlandini, C
Del Tacca, M
Conte, PF
Citation: A. Gennari et al., The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer, SEMIN ONCOL, 27(1), 2000, pp. 14-19
Authors:
Costantini, M
Balzi, D
Garronec, E
Orlandini, C
Parodi, S
Vercelli, M
Bruzzi, P
Citation: M. Costantini et al., Geographical variations of place of death among Italian communities suggest an inappropriate hospital use in the terminal phase of cancer disease, PUBL HEAL, 114(1), 2000, pp. 15-20
Authors:
Lencioni, M
Falcone, A
Allegrini, G
Pfanner, E
Masi, G
Brunetti, I
Di Marsico, R
Fontana, E
Orlandini, C
Stampino, CG
Bartolozzi, C
Conte, PF
Citation: M. Lencioni et al., Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study, ONCOL-BASEL, 59(3), 2000, pp. 204-209
Authors:
Ricci, S
Antonuzzo, A
Galli, L
Tibaldi, C
Bertuccelli, M
Pegna, AL
Petruzzelli, S
Bonifazi, V
Orlandini, C
Conte, PF
Citation: S. Ricci et al., A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma, CANCER, 89(8), 2000, pp. 1714-1719
Authors:
Gennari, A
Salvadori, B
Donati, S
Bengala, C
Orlandini, C
Danesi, R
Del Tacca, M
Bruzzi, P
Conte, PF
Citation: A. Gennari et al., Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors, J CL ONCOL, 17(11), 1999, pp. 3596-3602
Authors:
Zoli, M
Magalotti, D
Bianchi, G
Gueli, C
Orlandini, C
Grimaldi, M
Marchesini, G
Citation: M. Zoli et al., Total and functional hepatic blood flow decrease in parallel with ageing, AGE AGEING, 28(1), 1999, pp. 29-33
Risultati:
1-13
|